SHERP

Combined low dose cyclosporine and prednisone down-regulate natural killer cell-like effector functions of CD8brightCD56+ T cells in patients with active Behcet uveitis

Cited 0 time in webofscience Cited 4 time in scopus
Authors
Ahn, Jae Kyoun; Park, Yeoung Geol; Park, Sang Woo; Yoon, Kyung-Chul; Yu, Hyeong Gon; Chung, Hum
Issue Date
2006-09-24
Publisher
Taylor & Francis
Citation
Ocul Immunol Inflamm. 2006 Oct;14(5):267-75.
Keywords
AdultAntigens, CD56/*immunologyBehcet Syndrome/drug therapy/*immunologyCD8-Positive T-Lymphocytes/*physiologyCyclosporine/administration & dosageCytotoxicity Tests, ImmunologicDown-Regulation/*drug effectsDrug Therapy, CombinationFemaleFlow CytometryHumansImmunosuppressive Agents/*administration & dosageKiller Cells, Natural/*immunologyMaleMembrane Glycoproteins/metabolismMiddle AgedPerforinPhenotypePore Forming Cytotoxic Proteins/metabolismPrednisone/administration & dosageProspective StudiesReceptors, CCR5/metabolismReceptors, Interleukin-8A/metabolism
Abstract
PURPOSE: To investigate the changes of effector-related phenotypic markers and the natural killer (NK)-like effector functions of CD8(bright)CD56+ T cells in patients with Behcet uveitis after combined cyclosporine and prednisone (Cs/Pd) treatment. METHODS: Ten patients with active Behcet panuveitis and 10 healthy controls were prospectively recruited in this study. The effector-related surface markers (CD27, CD62L, CD11b, HLA-DR, CD94, NKG2D), chemokine receptors (CXCR1, CXCR3, CCR4, CCR5), and intracellular perforin of circulating CD8(bright)CD56+ T cells were determined by flow cytometric analysis before and after two months' treatment. NK-like cytotoxicity of ex vivo CD8(bright)CD56+ T cells against K562 was measured by standard 51Cr release assay. RESULTS: The expression levels of effector-related molecules on CD8(bright)CD56+ T cells normalized after treatment. The expression levels of CXCR1 and CCR5 were down-regulated on CD8(bright)CD56+ T cells after treatment. The amounts of preformed intracellular perforin of CD8(bright)CD56+ T cells were reduced to the normal levels. Furthermore, the NK-like cytolytic capacities of CD8(bright)CD56+ T cells were decreased after treatment. CONCLUSIONS: Our results suggest that the combined Cs/Pd treatments in active Behcet uveitis may downregulate the NK-like effector functions of CD8(bright)CD56+ T cells.
ISSN
0927-3948 (Print)
Language
English
URI
http://www.informaworld.com/smpp/content~db=all?content=10.1080/09273940600966616

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17056460

http://hdl.handle.net/10371/16150
DOI
https://doi.org/10.1080/09273940600966616
Files in This Item:
There are no files associated with this item.
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Ophthalmology (안과학전공)Journal Papers (저널논문_안과학전공)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse